Clinical Trials Browser

Phase 2 × Completed × Immune Checkpoint Inhibitors × Clear all

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung

NCT05166239 2026-01-23

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

Phase 2 Completed

66 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT05348668 2026-01-07

Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer

Phase 2 Completed

78 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05440916 2025-12-02

PRIMM

Phase 2 Completed

50 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04681131 2025-09-25

CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC

Phase 2 Completed

85 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT05509699 2025-08-29

Surufatinib Plus Anti-PD-1/L1 as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer

Phase 2 Completed

21 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT03984357 2025-07-17

PLATINUM

Phase 2 Completed

152 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04997382 2025-02-25

CLASSIC5

Phase 2 Completed

112 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03989336 2024-07-15

A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer

Phase 2 Completed

84 enrolled

Gynecologic

Ovarian Neoplasms, Recurrence

NCT03817736 2024-05-09

START-FIT

Phase 2 Completed

33 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03511391 2024-01-23

CHEERS

Phase 2 Completed

99 enrolled

DermatologicGenitourinaryHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Melanoma

Clinical Trials

Priming Immunotherapy in Advanced Disease With Radiation

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer

PRIMM

CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC

Surufatinib Plus Anti-PD-1/L1 as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer

PLATINUM

CLASSIC5

A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer

START-FIT

CHEERS